Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16098347rdf:typepubmed:Citationlld:pubmed
pubmed-article:16098347lifeskim:mentionsumls-concept:C0221198lld:lifeskim
pubmed-article:16098347lifeskim:mentionsumls-concept:C2711860lld:lifeskim
pubmed-article:16098347pubmed:issue5lld:pubmed
pubmed-article:16098347pubmed:dateCreated2005-8-15lld:pubmed
pubmed-article:16098347pubmed:abstractTextThis article provides an overview of current treatment approaches in patients with primary or secondary liver diseases. Emphasis is placed on MR imaging prior, during, and after various treatments, including liver resection, systemic chemotherapy, transcatheter arterial chemoembolization, ablative therapies, and liver transplantation. Findings described for MR imaging are directly applicable to findings for CT and potentially contrast-enhanced ultrasound. The authors' description, however, will deal mainly with MR imaging as this is the their preferred approach due to diagnostic accuracy and patient safety, and the findings are most demonstrative on MR imaging.lld:pubmed
pubmed-article:16098347pubmed:languageenglld:pubmed
pubmed-article:16098347pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16098347pubmed:citationSubsetAIMlld:pubmed
pubmed-article:16098347pubmed:statusMEDLINElld:pubmed
pubmed-article:16098347pubmed:monthSeplld:pubmed
pubmed-article:16098347pubmed:issn0033-8389lld:pubmed
pubmed-article:16098347pubmed:authorpubmed-author:SemelkaRichar...lld:pubmed
pubmed-article:16098347pubmed:authorpubmed-author:GullerUlrichUlld:pubmed
pubmed-article:16098347pubmed:authorpubmed-author:BragaLarissaLlld:pubmed
pubmed-article:16098347pubmed:issnTypePrintlld:pubmed
pubmed-article:16098347pubmed:volume43lld:pubmed
pubmed-article:16098347pubmed:ownerNLMlld:pubmed
pubmed-article:16098347pubmed:authorsCompleteYlld:pubmed
pubmed-article:16098347pubmed:pagination915-27, viiilld:pubmed
pubmed-article:16098347pubmed:dateRevised2005-11-16lld:pubmed
pubmed-article:16098347pubmed:meshHeadingpubmed-meshheading:16098347...lld:pubmed
pubmed-article:16098347pubmed:meshHeadingpubmed-meshheading:16098347...lld:pubmed
pubmed-article:16098347pubmed:meshHeadingpubmed-meshheading:16098347...lld:pubmed
pubmed-article:16098347pubmed:meshHeadingpubmed-meshheading:16098347...lld:pubmed
pubmed-article:16098347pubmed:meshHeadingpubmed-meshheading:16098347...lld:pubmed
pubmed-article:16098347pubmed:meshHeadingpubmed-meshheading:16098347...lld:pubmed
pubmed-article:16098347pubmed:meshHeadingpubmed-meshheading:16098347...lld:pubmed
pubmed-article:16098347pubmed:meshHeadingpubmed-meshheading:16098347...lld:pubmed
pubmed-article:16098347pubmed:meshHeadingpubmed-meshheading:16098347...lld:pubmed
pubmed-article:16098347pubmed:meshHeadingpubmed-meshheading:16098347...lld:pubmed
pubmed-article:16098347pubmed:year2005lld:pubmed
pubmed-article:16098347pubmed:articleTitlePre-, peri-, and posttreatment imaging of liver lesions.lld:pubmed
pubmed-article:16098347pubmed:affiliationDepartment of Radiology, School of Medicine, University of North Carolina at Chapel Hill, 101 Manning Drive, CB 7510, Chapel Hill, NC 27599-7510, USA.lld:pubmed
pubmed-article:16098347pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:16098347pubmed:publicationTypeReviewlld:pubmed